#ThinkSabio US Market Morning Brief

Pre-Market Gainers:
$NVVE +69%
$BDTX +42%: Black Diamond Therapeutics to present initial Phase 2 data on BDTX-1535 in patients with recurrent EGFRm NSCLC
$VYTX +24%: VYTX announces $27M strategic investment from Sanofi ($SNY)

Pre-Market Decliners:
$ZJYL -22%
$FRES -18%
$GP -15%

Pre-Market Penny Gainers:
$XPON +62%
$TGL +39%
$NUKK +35%

Headlines:
$NVDA: Speculation grows in China over H20 chip discontinuation ahead of US export control review - Digitimes.
$BHVN: Plans to submit NDA for Troriluzole to treat all SCA genotypes in Q4, eligible for priority review.